Aesica Introduces New Service Model

Aesica has introduced a new service model aimed at solving multiple supply chain challenges, under which the company will take on the management of other CDMOs, while serving as the single point of customer contact.
 
This model allows Aesica to reduce the number of CDMOs the customer previously had to manage, and identify the most strategically useful and effective CDMOs to engage in projects.The service aims to streamline processes and create a simplified supply chain structure, reducing the overall number of supplier relationships, while maintaining a consistent outsourcing approach across an entire portfolio. It is also designed to optimize efficiency, eliminate waste and supply shortages, and to achieve cost savings.
 
Aesica currently manages a portfolio of more than 10 different CDMOs and has a dedicated team responsible for ensuring total process management across an entire supply chain. This includes procurement to manage the relationship, risk assessment and price negotiations between customers, Aesica and the other CDMOs, as well as manage QC and QA activities.
 
The model is primarily geared to small and medium sized CDMOs, facing the same price pressures as big pharma, while lacking all the resources required for managing multiple CDMOs. It is also suited to companies that have diverse portfolios with affiliates or licensees based across multiple geographic regions.
  
Garry Hodges, operations director, Aesica Pharmaceuticals said, “We are very pleased to have brought our new business model to the market to help meet the pressing demand from the pharma market for solutions that improve, streamline and significantly simplify their supply chains. Our business model helps our customers to lower their costs, reduce risk and to be faster to market.”